Fengshen Kuo

41PUBLICATIONS
262CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Solid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jan 28, 2026
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.

Manu Prasad, Alex T Cheng, Marcel Mayer

|Dec 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Ziyu Chen, Xinran Tang, Jordan E Eichholz

|Feb 25, 2025
Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma.

Simran Makker, Neil J Shah, Maria I Carlo

|Jan 13, 2025
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters.

Naitao Wang, Mohini R Pachai, Dan Li

|Jan 06, 2025
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data.

Seong-Keun Yoo, Conall W Fitzgerald, Byuri Angela Cho

|Oct 01, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.

Antoine Desilets, Joris L Vos, Nora Katabi

Pageof 7

Frequent Collaborators

16 joint publications

Timothy A Chan

16 joint publications

Luc Gt Morris

12 joint publications

Abraham Ari Hakimi

7 joint publications

Ed Reznik